Evidence mapPaperPMID 41154683Full record

ArticleBiomolecules2025

Yale Tang, Chao Wang, Luxuan Li, Xiaoyu Wang, Linquan Yang, Xing Wang, Luping Ren, Guangyao Song

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yale TangDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang 050017, China.
Chao WangHebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang 050051, China.
Luxuan LiDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang 050017, China.
Xiaoyu WangDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang 050017, China.
Linquan YangHebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang 050051, China.
Xing WangHebei Key Laboratory of Metabolic Diseases, Hebei General Hospital, Shijiazhuang 050051, China.
Luping RenDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang 050017, China.
Guangyao SongDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang 050017, China.

Funding

National Natural Science Foundation of China 82170878
6 · The paper itself

Abstract

This study aimed to investigate whether knockout of the

Indexed as

Apolipoprotein B-48Diet, High-FatAnimalsAtherosclerosisCeramidesInsulin ResistanceLipid MetabolismMaleMiceMice, Inbred C57BLMice, KnockoutApolipoprotein B-48Ceramideshyperlipidaemiaknockoutmetabolism

Identifiers

PMID41154683
PMCPMC12564635

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.